{"id":12919,"date":"2017-01-02T14:16:35","date_gmt":"2017-01-02T14:16:35","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=12919"},"modified":"2017-02-21T13:33:20","modified_gmt":"2017-02-21T13:33:20","slug":"the-impact-of-adolescent-exposure-to-medical-marijuana-laws-on-high-school-completion-college-enrollment-and-college-degree-completion","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2017\/01\/the-impact-of-adolescent-exposure-to-medical-marijuana-laws-on-high-school-completion-college-enrollment-and-college-degree-completion\/","title":{"rendered":"The impact of adolescent exposure to medical marijuana laws on high school completion, college enrollment and college degree completion."},"content":{"rendered":"<p>Abstract<\/p>\n<p>BACKGROUND:<\/p>\n<p>There is concern that medical marijuana laws (MMLs) could negatively affect adolescents. To better understand these policies, we assess how adolescent exposure to MMLs is related to educational attainment.<\/p>\n<p>METHODS:<\/p>\n<p>Data from the 2000 Census and 2001-2014 American Community Surveys were restricted to individuals who were of high school age (14-18) between 1990 and 2012 (n=5,483,715). MML exposure was coded as: (i) a dichotomous &#8220;any MML&#8221; indicator, and (ii) number of years of high school age exposure. We used logistic regression to model whether MMLs affected: (a) completing high school by age 19; (b) beginning college, irrespective of completion; and (c) obtaining any degree after beginning college. A similar dataset based on the Youth Risk Behavior Survey (YRBS) was also constructed for confirmatory analyses assessing marijuana use.<\/p>\n<p>RESULTS:<\/p>\n<p>MMLs were associated with a 0.40 percentage point increase in the probability of not earning a high school diploma or GED after completing the 12th grade (from 3.99% to 4.39%). High school MML exposure was also associated with a 1.84 and 0.85 percentage point increase in the probability of college non-enrollment and degree non-completion, respectively (from 31.12% to 32.96% and 45.30% to 46.15%, respectively). Years of MML exposure exhibited a consistent dose response relationship for all outcomes. MMLs were also associated with 0.85 percentage point increase in daily marijuana use among 12th graders (up from 1.26%).<\/p>\n<p>CONCLUSIONS:<\/p>\n<p>Medical marijuana law exposure between age 14 to 18 likely has a delayed effect on use and education that persists over time.<\/p>\n<p><em> Source:\u00a0 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27742490 Drug Alcohol Depend. 2016 Nov 1;168:320-327. doi: 10.1016\/j.drugalcdep.2016.09.002. Epub 2016 Oct 11.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract BACKGROUND: There is concern that medical marijuana laws (MMLs) could negatively affect adolescents. To better understand these policies, we assess how adolescent exposure to MMLs is related to educational attainment. METHODS: Data from the 2000 Census and 2001-2014 American Community Surveys were restricted to individuals who were of high school age (14-18) between 1990 [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41,62,90,60],"tags":[],"class_list":["post-12919","post","type-post","status-publish","format-standard","hentry","category-drug-use-effects-on-foetus","category-education","category-global-drug-legalisation-efforts","category-marijuana-and-medicine"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/12919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=12919"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/12919\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=12919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=12919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=12919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}